MSMauro SchechterMD, PhDSlidesetHIVSalvador HIV Clinical Forum 2019Role of INSTIs in HIV Prevention - Mauro Schechter, MD, PhDView Slideset
SlidesetHIVSalvador HIV Clinical Forum 2019Switching to INSTI-Based Treatment in Viral Suppressed Patients - Ian Frank, MDView Slideset
RDRicardo DiazMDSlidesetHIVSalvador HIV Clinical Forum 2019Experience with Dolutegravir in First-Line in Brazil - Ricardo Diaz, MDView Slideset
CBCharles BoucherMD, PhDSlidesetHIVSalvador HIV Clinical Forum 2019Resistance to INSTIs and How Resistance Impacts Treatment Choices - Charles Boucher, MD, PhDView Slideset
SlidesetHIVSalvador HIV Clinical Forum 2019Toxicity Considerations When Choosing INSTIs - Ian Frank, MDView Slideset
DBDavid BackPhDSlidesetHIVSalvador HIV Clinical Forum 2019Pharmacology Considerations When Choosing INSTIs - David Back, PhDView Slideset
SlidesetHIVInternational Workshop on HIV and Transgender People 2020Surgeries and Body Modification Services - Rodrigo ItocazoView Slideset
SlidesetHIVInternational Workshop on HIV and Transgender People 2020Overview of Epidemiology and Drivers of HIV in Transgender Communities - Sari ReisnerView Slideset
SlidesetHIVInternational Workshop on HIV and Transgender People 2020Non-Surgical Body and Facial Modification - Isabella VenturaView Slideset
SlidesetHIVInternational Workshop on HIV and Transgender People 2020Health and HIV Services for Sex Workers Service Provider's Perspective - Sjaak van der KolkView Slideset
SW(BS. Wilson (Will) BeckhamPhD, MPHSlidesetHIVInternational Workshop on HIV and Transgender People 2020Impact of COVID-19 on Transgender Communities Globally - Will BeckhamView Slideset
